2022
DOI: 10.1016/j.actbio.2022.07.067
|View full text |Cite
|
Sign up to set email alerts
|

Injectable mesoporous bioactive nanoparticles regenerate bone tissue under osteoporosis conditions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(11 citation statements)
references
References 62 publications
0
11
0
Order By: Relevance
“…A composite hydrogel composed of mesoporous bioactive glass achieved differentiated delivery modes for osteogenic recombinant human bone morphogenetic protein-2 and angiogenic vascular endothelial growth factor [ 85 ] and promoted osteogenic differentiation of primary mouse bone marrow stromal stem cells and angiogenesis [ 86 ]. More than that, a mesoporous bioactive glass-loaded composite hydrogel improved bone regeneration in some extreme conditions, such as osteoporosis [ 87 ], oxidative stress [ 88 ], and tumor microenvironments [ 89 ].…”
Section: Classification Of Mesoporous Material-loaded Composite Hydro...mentioning
confidence: 99%
“…A composite hydrogel composed of mesoporous bioactive glass achieved differentiated delivery modes for osteogenic recombinant human bone morphogenetic protein-2 and angiogenic vascular endothelial growth factor [ 85 ] and promoted osteogenic differentiation of primary mouse bone marrow stromal stem cells and angiogenesis [ 86 ]. More than that, a mesoporous bioactive glass-loaded composite hydrogel improved bone regeneration in some extreme conditions, such as osteoporosis [ 87 ], oxidative stress [ 88 ], and tumor microenvironments [ 89 ].…”
Section: Classification Of Mesoporous Material-loaded Composite Hydro...mentioning
confidence: 99%
“…Pontremoli et al reported the use of MBGNs embedded into hydrogels as injectable platforms for the in situ delivery of therapeutic ions [ 140 ]. This strategy has very recently allowed us to deliver MBGNs as intraosseous biomaterials via minimally invasive surgery in an osteoporotic animal model to evaluate the bone regenerative capability of both MBGNs and MBGNs loaded with ipriflavone as an anti-osteoporotic drug (MBGN/IPs) [ 141 ]. Previously, our research group had widely studied the in vitro specific cell responses to MBGNs and MBGN/IPs with cell types involved in bone remodeling, osteogenesis, angiogenesis, and immune response, evidencing the high potential of these nanoparticles for use as drug delivery systems in bone repair and osteoporosis treatments [ 23 , 121 , 125 ].…”
Section: In Vivo Studiesmentioning
confidence: 99%
“…Thus, MBNPs promoted bone regeneration with a moderate inflammatory response, as histological analyses have evidenced. On the other hand, MBGN/IPs produced a higher presence of osteoblasts and enhanced angiogenesis at the defect site, but without showing significant differences in terms of new bone formation [ 141 ].…”
Section: In Vivo Studiesmentioning
confidence: 99%
“…Although mesoporous bioactive materials are not yet in routine clinical use, they have emerged as effective preclinical strategies for bone regeneration. For example, the high osteogenic capability of mesoporous bioactive nanoparticles has been demonstrated in an osteoporotic rabbit model [ 46 ] . Novel biomaterial developments are needed to further improve 3DP scaffold systems so that the 328 simultaneous requirements for mechanical and bioactive properties to induce successful bone healing can be met.…”
Section: 22 3dp Materialsmentioning
confidence: 99%